Mallinckrodt working with u.s. fda on possibility of making company's inomax gas

Mallinckrodt and novoteris receive clearance from health canada to start pilot trial of high-dose inhaled nitric oxide therapy for covid-19 infection and associated lung complications.mallinckrodt plc - currently working with u.s. fda on possibility of making company's inomax gas, for inhalation product available to u.s. patients.mallinckrodt - study to investigate antiviral activity, improvement in oxygenation and pulmonary arterial pressure in patients suffering from covid-19.
MNK Ratings Summary
MNK Quant Ranking